4-nitro-1H-indene | 202749-18-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚和异茚
• 英文名称: 4-nitro-1H-indene
• CAS: 202749-18-6
• 化学式: C₉H₇NO₂
• 分子量: 161.16
• InChiKey: UYWPMMCADZIKSA-UHFFFAOYSA-N

物化性质

• 沸点：
  284.3±29.0 °C(Predicted)
• 密度：
  1.303±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-nitro-1H-indene 在 ammonium hydroxide 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 生成
  参考文献：
  名称：

  Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel

  摘要：

  A collection of aryl sulfonamido indanes based on the lead compound I was synthesized and evaluated for Kv1.5 inhibitory activity. Kv1.5 inhibitors have the potential to be atrium-selective agents for treatment of atrial fibrillation. (1R,2R)-1 has an IC50 of 0.033 mu M against Kv1.5 and is selective against other cardiac ion channels, including hERG. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.02.052
• 作为产物：
  描述：

  茚满 在 sodium tetrahydroborate 、 rhodium(III) chloride 、 硫酸 、 硝酸 、 对甲苯磺酸 作用下， 以 甲醇 、 乙醇 、 甲苯 为溶剂， 生成 4-nitro-1H-indene
  参考文献：
  名称：

  Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel

  摘要：

  A collection of aryl sulfonamido indanes based on the lead compound I was synthesized and evaluated for Kv1.5 inhibitory activity. Kv1.5 inhibitors have the potential to be atrium-selective agents for treatment of atrial fibrillation. (1R,2R)-1 has an IC50 of 0.033 mu M against Kv1.5 and is selective against other cardiac ion channels, including hERG. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.02.052

文献信息

• US3943149A
  申请人：——

  公开号：US3943149A

  公开（公告）日：1976-03-09
• Aryl sulfonamido indane inhibitors of the Kv1.5 ion channel
  作者：Michael F. Gross、Serge Beaudoin、Grant McNaughton-Smith、George S. Amato、Neil A. Castle、Christine Huang、Anruo Zou、Weifeng Yu

  DOI：10.1016/j.bmcl.2007.02.052

  日期：2007.5

  A collection of aryl sulfonamido indanes based on the lead compound I was synthesized and evaluated for Kv1.5 inhibitory activity. Kv1.5 inhibitors have the potential to be atrium-selective agents for treatment of atrial fibrillation. (1R,2R)-1 has an IC50 of 0.033 mu M against Kv1.5 and is selective against other cardiac ion channels, including hERG. (c) 2007 Elsevier Ltd. All rights reserved.